(Q42990108)

English

Sustained virologic response after therapy with the HCV protease inhibitor narlaprevir in combination with peginterferon and ribavirin is durable through long-term follow-up.

scientific article published on 7 January 2013

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23490393%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Sustained virologic response after therapy with the HCV protease inhibitor narlaprevir in combination with peginterferon and ribavirin is durable through long-term follow-up (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23490393%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

0 references

1 reference

based on heuristic

inferred from title

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23490393%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23490393%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

author name string

D M Hotho

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23490393%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

J de Bruijne

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23490393%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

M A Treitel

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23490393%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

R J de Knegt

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23490393%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

H L A Janssen

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23490393%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

H W Reesink

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23490393%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

publication date

7 January 2013

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23490393%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Journal of Viral Hepatitis

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23490393%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

20

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23490393%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23490393%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

e78-81

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23490393%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12012

21 January 2018

Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12012

21 January 2018

Telaprevir and peginterferon with or without ribavirin for chronic HCV infection

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12012

21 January 2018

Analysis of HCV resistance mutations during combination therapy with protease inhibitor boceprevir and PEG-IFN alpha-2b using TaqMan mismatch amplification mutation assay

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12012

21 January 2018

Inflammatory markers neopterin and alanine aminotransferase in HCV patients treated with HCV NS3.4A protease inhibitor telaprevir (VX-950) and/or peginterferon alfa-2a

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12012

21 January 2018

Functional and therapeutic analysis of hepatitis C virus NS3.4A protease control of antiviral immune defense

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12012

21 January 2018

Sporadic reappearance of minute amounts of hepatitis C virus RNA after successful therapy stimulates cellular immune responses

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12012

21 January 2018

Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12012

21 January 2018

Antiviral activity of narlaprevir combined with ritonavir and pegylated interferon in chronic hepatitis C patients

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12012

21 January 2018

Retention of CD4+ CD25+ FoxP3+ regulatory T cells in the liver after therapy-induced hepatitis C virus eradication in humans

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12012

21 January 2018

A sustained virologic response is durable in patients with chronic hepatitis C treated with peginterferon alfa-2a and ribavirin

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12012

21 January 2018

Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12012

21 January 2018

Hepatitis C virus persistence after spontaneous or treatment-induced resolution of hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12012

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42990108&oldid=1591630972"